Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-03-14 Sale | 2025-03-18 5:30 pm | Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO | 46,668 | $1.96 | $91,469 | 8,189,765 (Indirect Direct) | View |
| 2025-02-03 Sale | 2025-02-05 4:13 pm | Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO | 46,003 | $1.68 | $77,285 | 8,230,433 (Indirect Direct) | View |
| 2022-03-15 Sale | 2022-03-17 5:59 pm | Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO | 23,648 | $7.6488 | $180,879 | 5,202,848 (Indirect Direct) | View |
| 2021-03-15 Sale | 2021-03-17 5:00 pm | Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO | 20,513 | $38.57 | $791,271 | 4,706,057 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-01-24 Option Award | 2025-01-28 8:10 pm | N/A 2035-01-24 | Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO | 2,504,304 | $0 | 10,228,566 (Direct) | View |
| 2024-05-16 Option Award | 2024-05-20 6:01 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO | 344,828 | $2.9 | 7,723,302 (Direct) | View |
| 2024-03-14 Tax Withholding | 2024-03-18 8:10 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO | 53,393 | $4.33 | 7,378,474 (Direct) | View |
| 2024-01-25 Option Award | 2024-01-31 5:42 pm | N/A 2034-01-25 | Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO | 1,441,335 | $0 | 8,549,934 (Direct) | View |
| 2023-03-22 Option Award | 2023-03-24 8:13 pm | N/A 2033-03-22 | Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO | 3,416,664 | $0 | 8,599,307 (Direct) | View |
| 2023-03-14 Tax Withholding | 2023-03-16 5:32 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO | 22,340 | $5.56 | 5,182,643 (Direct) | View |
| 2022-03-23 Option Award | 2022-03-25 5:51 pm | N/A 2032-03-23 | Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO | 2,195,512 | $0 | 2,195,512 (Direct) | View |
| 2021-05-24 Exercise | 2021-05-26 08:00 am | N/A 2030-03-18 | Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO | 27,410 | $0 | 5,766,665 (Direct) | View |
| 2021-05-24 Exercise | 2021-05-26 08:00 am | N/A N/A | Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO | 27,410 | $18.22 | 5,766,665 (Direct) | View |
| 2020-08-31 Gift(A) | 2021-04-02 4:11 pm | N/A N/A | Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO | 205,778 | $0 | 4,342,021 (Indirect) | View |
| 2021-03-26 Option Award | 2021-03-30 4:57 pm | N/A 2031-03-26 | Allogene Therapeutics Inc. | ALLO | Chang David D President and CEO | 379,288 | $0 | 5,085,345 (Direct) | View |